These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11539872)

  • 21. Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial.
    Cutter NC; Scott DD; Johnson JC; Whiteneck G
    Arch Phys Med Rehabil; 2000 Feb; 81(2):164-9. PubMed ID: 10668769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis.
    Mueller ME; Gruenthal M; Olson WL; Olson WH
    Arch Phys Med Rehabil; 1997 May; 78(5):521-4. PubMed ID: 9161373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oscillatory eye movements resembling pendular nystagmus in normal juvenile macaques.
    Shichinohe N; Barnes G; Akao T; Kurkin S; Fukushima J; Kase M; Leigh RJ; Belton T; Fukushima K
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3458-67. PubMed ID: 21296810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unilateral Pendular Nystagmus in Multiple Sclerosis: A Case Series.
    Vosoughi AR; Barbosa NB; Micieli J; Margolin E
    J Neuroophthalmol; 2024 Sep; 44(3):414-418. PubMed ID: 37486916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gabapentin for relief of spasticity associated with multiple sclerosis.
    Dunevsky A; Perel AB
    Am J Phys Med Rehabil; 1998; 77(5):451-4. PubMed ID: 9798839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survey of management of acquired nystagmus in the United Kingdom.
    Choudhuri I; Sarvananthan N; Gottlob I
    Eye (Lond); 2007 Sep; 21(9):1194-7. PubMed ID: 16732211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder.
    Corá-Locatelli G; Greenberg BD; Martin J; Murphy DL
    J Clin Psychiatry; 1998 Sep; 59(9):480-1. PubMed ID: 9771822
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduction of fasciculations in patients with amyotrophic lateral sclerosis with the use of gabapentin.
    Romano JG
    Arch Neurol; 1996 Aug; 53(8):716. PubMed ID: 8759976
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of Gabapentin/Memantine on the Infantile Nystagmus Syndrome in the Zebrafish Model: Implications for the Therapy of Ocular Motor Diseases.
    Bögli SY; Afthinos M; Huang MY
    Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3149-3157. PubMed ID: 28632848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gabapentin in the treatment of cocaine dependence: a case series.
    Myrick H; Henderson S; Brady KT; Malcolm R
    J Clin Psychiatry; 2001 Jan; 62(1):19-23. PubMed ID: 11235923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropharmacologic aspects of the ocular motor system and the treatment of abnormal eye movements.
    Leigh RJ; Ramat S
    Curr Opin Neurol; 1999 Feb; 12(1):21-7. PubMed ID: 10097880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy.
    Petroff OA; Rothman DL; Behar KL; Lamoureux D; Mattson RH
    Ann Neurol; 1996 Jan; 39(1):95-9. PubMed ID: 8572673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Charles Bonnet's syndrome: complete remission of complex visual hallucinations treated by gabapentin.
    Paulig M; Mentrup H
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):813-4. PubMed ID: 11430294
    [No Abstract]   [Full Text] [Related]  

  • 34. The pharmacological treatment of nystagmus: a review.
    McLean RJ; Gottlob I
    Expert Opin Pharmacother; 2009 Aug; 10(11):1805-16. PubMed ID: 19601699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The characteristics and mechanisms of visual disturbance associated with anticonvulsant therapy.
    Remler BF; Leigh RJ; Osorio I; Tomsak RL
    Neurology; 1990 May; 40(5):791-6. PubMed ID: 2330106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of ataxia in cortical cerebellar atrophy with the drug gabapentin.
    Gazulla J; Errea J; Benavente I; Tordesillas C
    Clin Neuropharmacol; 2003; 26(5):225-6. PubMed ID: 14520159
    [No Abstract]   [Full Text] [Related]  

  • 37. The pharmacological treatment of acquired nystagmus.
    Mehta AR; Kennard C
    Pract Neurol; 2012 Jun; 12(3):147-53. PubMed ID: 22661344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gabapentin attenuates superior oblique myokymia.
    Tomsak RL; Kosmorsky GS; Leigh RJ
    Am J Ophthalmol; 2002 May; 133(5):721-3. PubMed ID: 11992881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gabapentin and carbamazepine affect eye movements and posture control differently: a placebo-controlled investigation of acute CNS side effects in healthy volunteers.
    Noachtar S; von Maydell B; Fuhry L; Büttner U
    Epilepsy Res; 1998 Jun; 31(1):47-57. PubMed ID: 9696300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weight gain and gabapentin therapy.
    Gidal BE; Maly MM; Nemire RE; Haley K
    Ann Pharmacother; 1995 Oct; 29(10):1048. PubMed ID: 8845546
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.